Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

Market Cap	17.05B
Revenue (ttm)	1.42B
Net Income (ttm)	89.86M
Shares Out	264.98M
EPS (ttm)	0.34
PE Ratio	189.44
Forward PE	88.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,990,455
Average Volume	20,227,633
Open	65.63
Previous Close	63.71
Day's Range	63.00 - 66.56
52-Week Range	26.61 - 77.77
Beta	-0.60
RSI	61.59
Earnings Date	Aug 27, 2025

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments. It pro...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 867
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300049

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.